ADHD Drugs for Alzheimer’s Apathy?
By
Simon Spichak, MSc
| August 11th, 2022
Scientists in the UK found that ADHD drugs might be the answer to treating apathy in people with Alzheimer’s disease. At least one in…
COVID-19 and Cognitive Impairment: New Risks, New Protective Strategies
By
Simon Spichak, MSc
| August 1st, 2022
At AAIC, scientists from around the world shared new findings on COVID-19 risk factors for cognitive impairment, as well as factors could help protect…
Alzheimer’s Blood Tests Take Another Step Forward
By
Phil Gutis
| August 1st, 2022
At this year’s AAIC, the developer of an Alzheimer’s blood test debuts promising data, while the Alzheimer’s Association warns new blood-based biomarkers aren’t quite…
Being There for Black Alzheimer’s Caregivers: GeVonna Fassett’s Story
By
Elena Ferrarin
| August 1st, 2022
Alzheimer’s advocate GeVonna Fassett spent more than a decade caring for her late mother. Today, her organization, Olivia’s Prayer, supports dementia caregivers and raises…
Phil’s Journal: Bringing the Patient’s Perspective to AAIC
By
Phil Gutis
| July 29th, 2022
In the midst of a media frenzy around fraud allegations and a key Alzheimer’s drug target, reporter Phil Gutis reflects on his personal experience…
Q&A: Can the MIND Diet Slow Down Alzheimer’s?
By
Deborah Kan
| July 28th, 2022
A study found that closely following the MIND diet for brain health appeared to cut peoples’ Alzheimer’s risk in half. The diet’s creator discusses…
Catching the Flu Could Triple Alzheimer’s Risk, Study Finds
By
Simon Spichak, MSc
| July 28th, 2022
Respiratory infections — including COVID-19 and also the common flu — more than double the risk of Parkinson’s, and more than triple the risk…